Jamey Millar, Novo Nordisk's Executive Vice President of US Operations, discussed the company's preparations for the upcoming CMS bridge program, which will impact Medicare beneficiaries' access to obesity treatments. Millar highlighted uncertainty about whether patient volume will surge immedia...
Source: [Bloomberg Markets](https://www.bloomberg.com/news/videos/2026-06-24/novo-nordisk-us-evp-on-wegovy-s-franchise-halo-effect-video)